Detection of designer drugs in human hair by ion mobility spectrometry (IMS)

Forensic Science International

Volumn 94, Issue 1-2, 1998, Pages 55-63

  Keller, Thomas ^a   Miki, Akihiro ^b   Regenscheit, Priska ^c   Dirnhofer, Richard ^c   Schneider, Andrea ^a   Tsuchihashi, Hitoshi ^b  

^a UNIVERSITY OF SALZBURG   (Austria)

^b OSAKA PREFECTURE UNIVERSITY   (Japan)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Designer drugs; Human hair; Internal standard; Ion mobility spectrometry; MDEA ('Eve'); MDMA ('ecstasy', 'Adam')

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DESIGNER DRUG;

ARTICLE; CASE REPORT; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; POLLUTANT; PRIORITY JOURNAL; SPECTROMETRY; STANDARD; TECHNIQUE;

EID: 0032496680     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(98)00051-6     Document Type: Article

References (39)

1. Yelverton B.J. Analysis of RDX vapors in pre- and post-detonations using the ion mobility spectrometer under field conditions. J. Energetic Mater. 6:1988;73-80.
2. Keller Th., Chlewinski A., Binz R., Regenscheit P., Dirnhofer R. IMS und HPLC im Kampf gegen Sprengstoffattentate. Kriminalistik. 7:1996;513-517.
3. R.K. Ritchie, A. Rudolph, Environmental application for ion mobility spectrometry, Proc. 3rd. Int. Workshop on Ion Mobility Spectrometry Galveston, TX, 1994, pp. 193-208.
4. C.S. Giam, G.E. Reed, T.L. Holliday, L. Chang, B.J. Rhodes, Direct analysis of organic priority pollutants by IMS, Proc. 3rd. Int. Workshop on Ion Mobility Spectrometry Galveston, TX, 1994, pp. 209-213.
5. L.L. Danylewich-May, P.C.P. Thomson, K. Wood, The use of IMS as a contraband detector, Proc. of Contraband and Cargo Inspection, Int. Technology Symposium, ONDCP/NIJ, Washington DC, 1992, pp.285-294.
6. Keller Th., Binz R., Regenscheit P., Bernhard W., Dirnhofer R. Ionenmobilitätsspektrometrie (IMS) in der Forensischen Analytik und Kriminalistik Teil I. Kriminalistik. 1:1996;67-70.
7. Keller Th., Binz R., Regenscheit P., Bernhard W., Dirnhofer R., Chlewinski A. Ionenmobilitätsspektrometrie (IMS) in der Forensischen Analytik und Kriminalistik Teil II. Kriminalistik. 2:1996;137-141.
8. Lawrence A.H. Ion mobility spectrometry/mass spectrometry of some prescription and illicit drugs. Anal. Chem. 58:1986;1269-1272.
9. Cohen M.J., Karasek F.W. Plasma chromatography - a new dimension for gas chromatography and mass spectrometry. J. Chromatogr. Sci. 8:1970;330-337.
10. R.A. de Zeeuw, A. Kode, L. Kim, L. Cacciacarro, Hair analysis by ion mobility spectrometry, Proc. 1995 Int. Conf. and Workshop For Hair Analysis in Forensic Toxicology, Abu Dhabi, 1995, pp. 334-350.
11. Miki A., Keller Th., Regenscheit P., Dirnhofer R., Tatsuno M., Katagi M., Nishikawa M., Tsuchihashi H. Application of ion mobility spectrometry to the rapid screening of methamphetamine incorporated in hair. J. Chromatogr. B. 692:1997;319-328.
12. Miki A., Keller Th., Regenscheit P., Bemhard W., Tatsuno M., Katagi M., Nishikawa M., Kim L., Hatano S., Tsuchihashi H. Detection of internal and external methamphetamine in human hair by ion mobility spectrometry. Jpn. J. Toxicol. Environ. Health. 43(1):1997;15-24.
13. R.P. Climko, H. Roerich, D.R. Sweeney, J. Al-Razi, Ecstasy: a review of MDMA and MDA, International Journal of Psychiatry in Medicine 16(4), 1986-1987, pp. 359-372.
14. D.E. Nichols, in: K.K. Redda, C.A. Walker, G. Bamett (Eds.), Cocaine, Marihuana, Designer Drugs: Chemistry, Pharmacology and Behaviour; CRC Press, Boca Raton, FL, 1989, pp. 181-184.
15. Suarez R.V., Riemersma R. Ecstasy and sudden cardiac death. Am. J. Forensic Med. Pathol. 9(4):1988;339-341.
16. Milroy C.M., Clark J.C., Forrest A.R.W. Pathology of deaths associated with ecstasy and eve misuse. J. Clin. Pathol. 49:1996;149-153.
17. Steele Th.D., McCann U.D., Ricaurte G.A. 3,4-Methylendioxymethamphetamine (MDMA, Ecstasy): pharmacology and toxicology in animals and humans. Addiction. 89:1994;539-551.
18. McCann U.D., Ridenour A., Shaham Y., Ricaurte G.A. Serotonin neurotoxicity after (±)-3,4-methylendioxymethamphetamine (MDMA) ecstasy: a controlled study in humans. Neuropsychopharmacology. 10(2):1994;129-138.
19. Marsh J.C.W., Abboudi Z.H., Gibson F.M., Scopes J., Daly S., O'Shaunnessy D.F., Baughan A.S.J., Gordon-Smith E.C. Aplastic anaemia following exposure to 3,4-methylendioxy/methamphetamine (Ecstasy). Br. J. Haematol. 88:1994;281-285.
20. Hughes J.C., McCabe M., Evans R.J. Intracranial haemorrhage associated with ingestion of Ecstasy. Arch. Emerg. Med. 10:1993;376-384.
21. Tehan B., Hadem R., Bodenham A. Hyperthermia associated with 3,4-methylendioxyethamphetamin (Eve). Anaesthesia. 48:1993;507-510.
22. Robinson T.E., Castaneda E., Whishaw I.Q. Effects of cortical serotonin depletion induced by 3,4-methylendioxymethamphetamine (MDMA) on behavior before and after additional cholinergic blockade, Neuropsychopharmacology. 8(2):1993;77-85.
23. Allen R.P., McCann U.D., Ricaurte G.A. Persistent effects of (+)-3,4-methylendioxymethamphetamine (MDMA, Ecstasy) on human sleep. Sleep. 16(6):1993;560-564.
24. Kovar K-A., Gouzoulis E., Hermle L., Spitzer M., Borchardt D. Psychological effects of MDE in normal subjects: are entactogens a new class of psychoactive agents? Neuropsychopharmacology. 8(2):1993;171-176.
25. Gouzoulis E., Bardeleben U.v., Rupp A., Kovar K.-A., Hermle L. Neuroendocrine and cardiovascular effects of MDE in healthy volunteers. Neuropsychopharmacology. 8(3):1993;187-193.
26. Rudnick G., Wall S.C. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol. Pharmacol. 43(2):1993;271-276.
27. Rudnick G., Wall S.C. The molecular mechanism of ecstasy [3,4-methylendioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA induced serotonin release. Proc. Natl. Acad. Sci. 89:1992;1817-1821.
28. Rohrig T.P., Prouty R.W. Tissue distribution of methylendioxymethamphetamine. Anal. Toxicol. 16:1992;52-53.
29. Kovar K.-A., Roesch C., Rupp A., Hermle L. Synthetische Suchtstoffe der 2. Generation (sog. Designer Drugs). Pharmazie in unserer Zeit. 3:1991;99-101.
30. McKenna D.J., Peroutka S.J. Neurochemistry and neurotoxicity of 3,4-methylendioxymethamphetamine (MDMA ecstasy). J. Neurochem. 54(1):1990;14-22.
31. Buchanan J.F., Brown C.R. Designer drugs: a problem in clinical toxicology. Med. Toxicol. 3:1988;1-17.
32. Stone D.M., Johnson M., Hanson G.R., Gibb J.W. A comparison of the neurotoxic potential of methylendioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134:1987;245-248.
33. Kintz P., Cirimele V., Tracqui A., Mangin P. Simultaneous determination of amphetamine, methamphetamine, 3,4-methylendioxyamphetamine and 3,4-methylendioxymethamphetamine in human hair by gas chromatography/mass spectrometry. J. Chromatogr. B. 670:1995;162-166.
34. Moeller M.R., Fey P., Sachs H. Hair analysis as evidence in forensic cases. Forensic Sci. Int. 63:1993;43-53.
35. G.A. Eiceman, Z. Karpas, Ion Mobility Spectrometry, CRC Press, Boca Raton, FL, 1994.
36. Siems W.F., Wu C., Tarver E.E., Hill H.H. Jr., Larsen P.R., McMinn D.G. Measuring the resolving power of ion mobility spectrometers. Anal. Chem. 66:1994;4195-4201.
37. Reategni J., Bacon T. Applications of ion mobility spectrometry in monitoring vapors. Process Control and Quality. 3:1992;209-218.
38. Hill H.H. Jr., Siems W.F., St. Louis R.H., McMinn D.G. Ion mobility spectrometry. Anal. Chem. 62(23):1990;1201A-1209A.
39. Karpas Z. Forensic applications of ion mobility spectrometry. Forensic Sci. Rev. 1:1989;104-119.